my account  log out
 

Ipamorelin

Create: 07/27/2016
Expired Date:07/31/2018
Category: Chemical
Message:Ipamorelin Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 Molecular formula: C38H49N9O5 Molar Mass: 711.85296 CAS number: 170851-70-4 PubChem: CID 20754357 Synonyms: Ipamorelin Acetate, IPAM, NNC-26-0161 The Ipamorelin Growth Hormone Releasing Peptide Comparison Ipamorelin is a 3rd generation GHRP behind GHRP-6 and GHRP-2. Ipamorelin has very similar characteristics of GHRP-2: does not have ghrelin's lipogenic properties and does not promote hunger. Ipamorelin acts synergistically when applied during a Growth Hormon Releasing Hormon (GHRH) pulse or when it is administered along with a GHRH or an analog such as Sermorelin or Modified GRF 1-29 (growth releasing factor, aminos 1-29). The synergy comes both due to the suppression of somatostatin and the fact that ipamorelin increases GH release per-somatotrope, while GHRH increases the number of somatotropes releasing GH. On the other hand, Ipamorelin is similar to GHRP-6 because they both release GH at a very similar strength minus the side effects that of GHRP-6. Both GHRP-6 and GHRP-2 cause a release and an increase in cortisol and prolactin levels, however Ipamorelin only selectively releases GH at any dose. Ipamorelin shares similar functionality to Hexarelin and compared to other peptides, it is a much more stable form of ghrelin and has longer half-life periods of at least two hours long and causes secondary effect by making neurons to become excited.
City:Wuhan[CN] 
Location:
 
Jul 28 2016Florinef Acetate393
Jul 28 2016desoxycortone393
Jul 28 2016hot sale cortisone Cortisone powder high purity431
Jul 28 2016Acetyl tetrapeptide-5 cas 820959-17-9 cosmetic peptides high quality438
Jul 28 2016High quality peptides Thymosin Alpha1 Acetate416
Jul 28 2016Terlipressin Acetate383
Jul 28 2016Tetracosactide Acetate379
Jul 28 2016Somatostatin Acetate423
Jul 28 2016Secretin Acetate418
Jul 28 2016Splenopentin Acetate377

return back

Copyright © toextrade Inc. All rights reserved. Contact us